Outcomes in patients ≥ 80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancy

Autor: Mairéad G McNamara, C Cipriano, R Hubner, A Lamarca, Hussain Raja, Xiaotian Wang, Alexandra R Lewis, A Rashed, Ward Re, Andrew M. Scott, Juan W. Valle, A Fitzpatrick
Rok vydání: 2019
Předmět:
Zdroj: Lewis, A R, Cipriano, C, Wang, X, Ward, R, Fitzpatrick, A, Scott, A R M, Rashed, A, Raja, H, Lamarca, A, Hubner, R A, Valle, J & Mcnamara, M 2019, ' Outcomes in patients ≥80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancy ', Medical Oncology . https://doi.org/10.1007/s12032-019-1310-0
ISSN: 1559-131X
DOI: 10.1007/s12032-019-1310-0
Popis: Introduction: Older patients are underrepresented in oncological clinical trials. The incidence of hepatopancreaticobiliary (HPB) malignancies is higher in older patients, but data on outcomes is lacking. Objectives: This study assessed patient outcomes in those 1) was not. Conclusions: Baseline factors were similar in both age cohorts, but more co-morbidities were present in older patients. Older patients were less likely to receive SACT, but when they did, they had an equivalent benefit in OS to younger patients.
Databáze: OpenAIRE